Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB. (Q40202490)
scientific article published on 20 October 2006
Language:
(P31) (Q13442814)
(P304) 351-358
(P407) (Q1860)
(P433) 3
(P478) 73
(P577) Friday, October 20, 2006
(P921) (Q29496)
(Q4833721)
(P1433) (Q864229)
(P1476) "Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB." (language: en)
(P2093) Caroline Smal
Stéphanie Lisart
Marie Maerevoet
Augustin Ferrant
Françoise Bontemps
Eric Van Den Neste
other details
description scientific article published on 20 October 2006

External Links